Clinical Trial Update: Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating different application rates of crisaborole 2% ointment in adults with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole 2% ointment (crisaborole)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Dermatitis, Atopic | Phase 4 | Status: COMPLETED